/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CNMDCONMED Corp |
|---|---|
| Last close | $51.94close 2026-11-09 |
| Change % | +0.85%close 2026-11-09 |
| Market cap | $1.5Bclose 2026-11-09 |
| P/E | 34.4FY to 2025-12-31 |
| Revenue | $1.4B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 5.2%FY to 2025-12-31 |
| Net income | $47M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0000816956-26-000047 · filed 2026-04-07 Open the filing on EDGAR →Open the XBRL payload →CiteCONMED Corp (CNMD), us-gaap:NetIncomeLoss: 47,100,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0000816956-26-000047, filed 2026-04-07. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000816956/us-gaap/NetIncomeLoss.json |
| Net margin | 3.4%FY to 2025-12-31 |
| EPS (diluted) | $1.51⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0000816956-26-000009 · filed 2026-02-17 Open the filing on EDGAR →Open the XBRL payload →CiteCONMED Corp (CNMD), us-gaap:EarningsPerShareDiluted: 1.51 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0000816956-26-000009, filed 2026-02-17. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000816956/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | 1.99FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | -2.76FY to 2025-12-31 |
| Next earnings | 01-22 → 02-01 |